Mereo BioPharma Group PLC ADR
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $500 | $0 | $1,064 | $0 |
Gross Profit | 368 | -271 | 532 | -284 |
EBITDA | -14,294 | -11,202 | -6,908 | -14,366 |
EBIT | -14,592 | -11,472 | -7,182 | -14,648 |
Net Income | -14,616 | -12,887 | -7,046 | -15,001 |
Net Change In Cash | 500 | 0 | 1,064 | 0 |
Free Cash Flow | -7,651 | -8,349 | -9,420 | -7,519 |
Cash | 56,125 | 62,483 | 69,802 | 80,522 |
Basic Shares | 159,887 | 156,855 | 155,145 | 154,029 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $10,000 | $1,507 | $36,464 |
Gross Profit | -1,088 | 7,426 | 571 | 18,556 |
EBITDA | -42,461 | -26,056 | -42,062 | -5,003 |
EBIT | -43,550 | -27,117 | -43,569 | -5,869 |
Net Income | -43,253 | -29,466 | -34,196 | 12,725 |
Net Change In Cash | 0 | 10,000 | 1,507 | 36,464 |
Free Cash Flow | -33,533 | -21,551 | -38,830 | -5,774 |
Cash | 69,802 | 57,421 | 56,334 | 94,296 |
Basic Shares | 147,924 | 131,890 | 120,639 | 116,734 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.02 |
2025-03-31 | -$0.01 |
2024-12-31 | -$0.01 |
